ACTR-44. PRELIMINARY RESULTS FROM THE NCT02770378 PROOF-OF-CONCEPT CLINICAL TRIAL ASSESSING THE SAFETY OF THE CUSP9v3 PROTOCOL COMBINED WITH METRONOMIC TEMOZOLOMIDE FOR RECURRENT GLIOBLASTOMA

BACKGROUND: Despite refinements of neurosurgical techniques and emerging adjuvant therapies, patients with recurrent glioblastoma continue to face a dismal prognosis. We report preliminary results of a clinical trial evaluating a protocol of 9 repurposed drugs (aprepitant, minocyclin, disulfiram, ce...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Halatsch, Marc-Eric, Kast, Richard, Karpel-Massler, Georg, Schmidt, Carl, Schmelzle, Birgit, Awad, Fadi, Panther, Patricia, Heiland, Tim
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2018
Matèries:
Abstracts
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6216384/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.076
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars